Better tools, better cancer immunotherapy

In the journal Science Immunology, researchers from DTU Health Technology and Jacobs University in Bremen have just published their cutting-edge research demonstrating advancement in detection of a certain type of immune cells, called T cells.

Possible targets to help tackle Crohn’s disease: The research has focused on different types of cells called macrophages, and how they work when bacteria are present

Affecting around 115,000 people in the UK alone, Crohn’s Disease is a lifelong condition which sees parts of the digestive system become inflamed. There is no precise cure and causes are believed to vary. But

Early antiretroviral treatment may preserve key immune responses to HIV: Ragon Institute study findings could pave the way to vaccine development

Instituting combination antiretroviral (ART) treatment at the earliest stages of HIV infection may allow the generation of functional CD8 “killer” T cells and preservation of the CD4 helper T cells that are the virus’s primary

Drug reduces risk of relapse with neuromyelitis optica

The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with neuromyelitis optica spectrum disorder (NMOSD). This rare but severe autoimmune inflammatory disorder can cause blindness, paralysis and